ES2113348T3 - Composiciones de vacunas estabilizadas. - Google Patents
Composiciones de vacunas estabilizadas.Info
- Publication number
- ES2113348T3 ES2113348T3 ES90913372T ES90913372T ES2113348T3 ES 2113348 T3 ES2113348 T3 ES 2113348T3 ES 90913372 T ES90913372 T ES 90913372T ES 90913372 T ES90913372 T ES 90913372T ES 2113348 T3 ES2113348 T3 ES 2113348T3
- Authority
- ES
- Spain
- Prior art keywords
- compositions
- stabilized vaccines
- vaccines
- stabilized
- diamins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- -1 AMINO GROUPS Chemical group 0.000 abstract 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229920000768 polyamine Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39399689A | 1989-08-15 | 1989-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2113348T3 true ES2113348T3 (es) | 1998-05-01 |
Family
ID=23557105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90913372T Expired - Lifetime ES2113348T3 (es) | 1989-08-15 | 1990-08-14 | Composiciones de vacunas estabilizadas. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5618539A (de) |
EP (1) | EP0487632B1 (de) |
JP (1) | JP3064413B2 (de) |
AT (1) | ATE163547T1 (de) |
CA (1) | CA2065023A1 (de) |
DE (1) | DE69032102T2 (de) |
DK (1) | DK0487632T3 (de) |
ES (1) | ES2113348T3 (de) |
WO (1) | WO1991002543A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4370451B2 (ja) * | 2001-09-28 | 2009-11-25 | 大塚製薬株式会社 | 医薬組成物 |
AU2003225057A1 (en) * | 2002-04-19 | 2003-11-03 | The Regents Of The University Of Michigan | Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens |
US20060110406A1 (en) * | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
EP1597400B8 (de) | 2003-02-25 | 2013-10-09 | MedImmune, LLC | Verfahren zur Herstellung von Influenza- Impfstoffzusammensetzungen |
US20060141483A1 (en) * | 2004-12-23 | 2006-06-29 | Calton Gary J | Stabilization of viral compositions |
TWI398272B (zh) * | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
BRPI0800357A2 (pt) * | 2008-03-10 | 2009-10-27 | Fundacao Oswaldo Cruz | método para produção de uma vacina estabilizada |
US20110212127A1 (en) * | 2008-09-24 | 2011-09-01 | Stabilitech Ltd. | Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
MX2011003074A (es) * | 2008-09-24 | 2011-04-19 | Stabilitech Ltd | Metodo para conservar polipeptidos utilizando un azucar y polietilenimina. |
BR112012025047A2 (pt) | 2010-03-31 | 2016-06-21 | Stabilitech Ltd | formulações líquidas estabilizadas |
HUE026885T2 (en) | 2010-03-31 | 2016-08-29 | Stabilitech Ltd | Stabilize virus fragments |
JP6023696B2 (ja) | 2010-03-31 | 2016-11-09 | スタビリテック リミテッド | ミョウバンアジュバントおよびミョウバンアジュバント化ワクチンの保存方法 |
CN103620025A (zh) * | 2011-06-28 | 2014-03-05 | 白血球保健股份有限公司 | 病毒或细菌的新型稳定方法 |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
US9283270B2 (en) | 2012-01-20 | 2016-03-15 | Serum Institute Of India Ltd. | Method for stabilization of biological molecules |
TWI690322B (zh) * | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
BR112015031541A2 (pt) * | 2013-06-17 | 2017-07-25 | De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport | métodos para o impedimento da agregação de componentes virais |
GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3097143A (en) * | 1960-03-30 | 1963-07-09 | Merck & Co Inc | Myristyl-gamma-picolinium chloride preserved polio vaccine and its production |
US3097142A (en) * | 1960-03-30 | 1963-07-09 | Merck & Co Inc | Benzyl alcohol stabilized polio vaccines and production thereof |
US3128229A (en) * | 1961-10-05 | 1964-04-07 | Baylor Medical Foundation | Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein |
GB1564998A (en) * | 1975-03-21 | 1980-04-16 | Connaught Lab | Vaccine and stabilizing solution therefor |
US4338335A (en) * | 1980-02-05 | 1982-07-06 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
US4337242A (en) * | 1980-02-05 | 1982-06-29 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
-
1990
- 1990-08-14 EP EP90913372A patent/EP0487632B1/de not_active Expired - Lifetime
- 1990-08-14 DE DE69032102T patent/DE69032102T2/de not_active Expired - Fee Related
- 1990-08-14 JP JP2512507A patent/JP3064413B2/ja not_active Expired - Fee Related
- 1990-08-14 CA CA002065023A patent/CA2065023A1/en not_active Abandoned
- 1990-08-14 WO PCT/US1990/004581 patent/WO1991002543A1/en active IP Right Grant
- 1990-08-14 DK DK90913372.0T patent/DK0487632T3/da active
- 1990-08-14 AT AT90913372T patent/ATE163547T1/de not_active IP Right Cessation
- 1990-08-14 ES ES90913372T patent/ES2113348T3/es not_active Expired - Lifetime
-
1994
- 1994-09-29 US US08/314,571 patent/US5618539A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0487632A1 (de) | 1992-06-03 |
US5618539A (en) | 1997-04-08 |
DE69032102T2 (de) | 1998-06-25 |
DE69032102D1 (de) | 1998-04-09 |
EP0487632B1 (de) | 1998-03-04 |
ATE163547T1 (de) | 1998-03-15 |
WO1991002543A1 (en) | 1991-03-07 |
JP3064413B2 (ja) | 2000-07-12 |
DK0487632T3 (da) | 1998-05-25 |
JPH04506973A (ja) | 1992-12-03 |
CA2065023A1 (en) | 1991-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2113348T3 (es) | Composiciones de vacunas estabilizadas. | |
ES2149267T3 (es) | Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral. | |
BR9201848A (pt) | Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos | |
DE3278344D1 (en) | Stabilization of influenza virus vaccine | |
ES2080119T3 (es) | Composicion suavizante de tejidos. | |
DK0639640T3 (da) | Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 | |
DE69129207T2 (de) | Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS | |
DK0559079T3 (da) | Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne | |
ES2053077T3 (es) | Piperidinil, pirrolidinil y piperazinil alquilfenol eteres con propiedades antirrinovirales. | |
DE68917348D1 (de) | Bor-dipeptid-Verbindungen, Methode zu deren Herstellung und pharmazeutische Anwendungen. | |
EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
ES8800358A1 (es) | Un procedimiento para preparar un polipeptido hibrido. | |
ES2132330T3 (es) | Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino. | |
DE3766984D1 (de) | Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids. | |
ES2058379T3 (es) | Monopersulfatos de acidos (poli)percarboxilicos heterociclicos conteniendo nitrogeno. | |
ES2096559T3 (es) | Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso. | |
BR9205877A (pt) | Processo e composiçao para o tratamento de infecçoes por herpes. | |
ES2084587T3 (es) | Arn virus no revertientes. | |
DK553587D0 (da) | Acylerede 9,10-anthracendicarboxaldehyd-bis-(2-imidazolin-2-ylhydrazoner), fremgangsmaade til deres fremstilling samt deres anvendelse | |
ES2056374T3 (es) | Mejoras en compuestos quimicos. | |
SU1483948A1 (ru) | Способ инактивации вируса везикулярной экзантемы свиней |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 487632 Country of ref document: ES |